DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
PF-04457845 is an investigational drug.
There have been 9 clinical trials for PF-04457845. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2012.
The most common disease conditions in clinical trials are Stress Disorders, Traumatic, Chronic Pain, and Stress Disorders, Post-Traumatic. The leading clinical trial sponsors are Pfizer, Yale University, and National Institute on Drug Abuse (NIDA).
Recent Clinical Trials for PF-04457845
|A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress Disorder||Pfizer||Phase 2|
|FAAH Inhibitor Trial for Adults With Tourette Syndrome||Tourette Association of America||Phase 2|
|FAAH Inhibitor Trial for Adults With Tourette Syndrome||Yale University||Phase 2|